Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002476635 | SCV002794300 | uncertain significance | Amelogenesis imperfecta type 1A; Junctional epidermolysis bullosa gravis of Herlitz; Junctional epidermolysis bullosa, non-Herlitz type | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001356996 | SCV001552313 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The LAMB3 p.R878C variant was reported in one individual with progressive multifocal leukoencephalopathy (van der Kolk_2016_PMID: 27042682). The variant was not reported in ClinVar, but it was identified in dbSNP (ID: rs199946321). The variant was identified in control databases in 11 of 251482 chromosomes at a frequency of 0.00004374 (Genome Aggregation Database March 6, 2019, v2.1.1). The p.R878 residue is conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |